Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
Gates Foundation

Africa: To better understand how to utilize currently approved COVID-19 vaccines in people living with HIV in order to achieve the most potent and long-lived immune responses

Last update: 1 day ago Last update: Mar 25, 2026

Details

Locations:South Africa
Start Date:Oct, 2022
End Date:Dec, 2026
Contract value: USD 3,817,329
Sectors:Health
 Health
Categories:Grants
Funding Agencies:
Gates Foundation
Date posted:Mar 25, 2026

Associated funding

Associated experts

Description

Purpose: To better understand how to utilize currently approved COVID-19 vaccines in people living with HIV in order to achieve the most potent and long-lived immune responses
Division: Global Health
Region served: AFRICA
Grant topic: HIV
Duration (months): 50
Grantee location: Parktown, Gauteng, South Africa

Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.
Learn more about our membership benefits
Print